Global Bio-Absorbable Stent Market, By Material (Bioresorbable Polymer-Based Stents, Bioresorbable Metallic Stents, Bioresorbable Natural Material-Based Stents), Product (Coronary Stents, Peripheral Stents, Stent-Related Implants), Absorption Rate (Slow-Absorption Stents, Fast-Absorption Stents), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals, Cardiac Centers, Specially Clinics/ Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
The bio-absorbable stent market is expected to witness market growth at a rate of 10.66% in the forecast period of 2021 to 2028. Data Bridge Market Research report on bio-absorbable stent market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rapid advancements in the healthcare sector globally is escalating the growth of bio-absorbable stent market.
Bio-absorbable stent refers to the type of medical equipment that is utilized in the treatment of cardiac abnormalities by expanding vessel for preventing blockage in blood vessels. The stents are generally implanted in the esophagus for offer food and beverages easy passage in esophageal cancer. These stents are implanted in the ureter to inhibit any obstruction in urine flow and varieties of stents for different clinical conditions are available.
The rise in the number of people suffering from coronary artery disease and peripheral artery disease across the globe acts as one of the major factors driving the growth of bio-absorbable stent market. The growing geriatric population and increased risk of CAD and PAD in the elderly, and rise in acceptance of medical implants among population accelerate the market growth. The increase in the inclination towards the minimally invasive procedures owning to various features such as lesser pain and faster recovery, and surge in percutaneous coronary intervention (PCI) procedure further influence the market. Additionally, improved healthcare infrastructure, strong product pipeline, increase in incidences of heart disease positively affects the bio-absorbable stent market. Furthermore, technological advancements in the stents extend profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand, high costs of stents procedure and risk associated with the use of bio-absorbable stents are expected to obstruct the market growth. Lack of trained medical professionals is projected to challenge the bio-absorbable stent market in the forecast period of 2021 to 2028.
This bio-absorbable stent market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on bio-absorbable stent market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Bio-Absorbable Stent Market Scope and Market Size
- The bio-absorbable stent market is segmented on the basis of material, product, absorption rate, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of material, the bio-absorbable stent market is segmented into bioresorbable polymer-based stents, bioresorbable metallic stents, and bioresorbable natural material-based stents.
- On the basis of product, the bio-absorbable stent market is segmented into coronary stents, peripheral stents and stent-related implants.
- On the basis of absorption rate, the bio-absorbable stent market is segmented into slow-absorption stents and fast-absorption stents.
- On the basis of application, the bio-absorbable stent market is segmented into coronary artery disease, and peripheral artery disease.
- On the basis of end user, the bio-absorbable stent market is segmented into hospitals, cardiac centers, specially clinics/ clinics and others.
Bio-Absorbable Stent Market Country Level Analysis
The bio-absorbable stent market is analyzed and market size insights and trends are provided by country, material, product, absorption rate, application and end user as referenced above.
The countries covered in the bio-absorbable stent market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Europe dominates the bio-absorbable stent market because of the increasing research activities for the development of bioresorbable stents within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the prevalence of CAD and PAD, and huge patient pool in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The bio-absorbable stent market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for bio-absorbable stent market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the bio-absorbable stent market. The data is available for historic period 2011-2019.
Competitive Landscape and Bio-Absorbable Stent Market Share Analysis
The bio-absorbable stent market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to bio-absorbable stent market.
The major players covered in the bio-absorbable stent market report are bbott, REVA Medical, Inc., Elixir Medical Corporation, KYOTO MEDICAL PLANNING Co., Ltd., BIOTRONIK, Amaranth Medical, Inc., Arterial Remodeling Technologies, Meril Life Sciences Pvt. Ltd., Arterius, lepumedical.com, Boston Scientific Corporation, 480 Biomedical, Inc., S3V Vascular Technologies., QualiMed, OrbusNeich, Medtronic, STENTYS SA, Terumo Corporation, MicroPort Scientific Corporation, BD, B. Braun, and Melsungen AG, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.